Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation
Device class 3 · Review panel CV
FDA PMA record
P210027
Original premarket approval. Product code OAE. Decision 23 November 2022.
Each row is one field of the openFDA record. The grey name is the field’s name in openFDA’s documentation.
| Field | Value | Field name |
|---|---|---|
| PMA number | P210027 | pma_number |
| Supplement number | null | supplement_number |
| Applicant | Biosense Webster, Inc. | applicant |
| Trade name | QDOT MICRO™ System | trade_name |
| Generic name | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | generic_name |
| Product code | OAE | product_code |
| Advisory committee | Cardiovascular | advisory_committee_description |
| Date received | 2021-07-06 | date_received |
| Decision date | 2022-11-23 | decision_date |
| Decision code | APPR | decision_code |
| Supplement type | empty | supplement_type |
| Supplement reason | empty | supplement_reason |
Source: FDA openFDA, device/pma, P210027, retrieved 2026-09-24 16:04 Eastern. Public domain (CC0).
The FDA classification record for the code on this record.
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation
Device class 3 · Review panel CV
ArrHub vocabulary
Electrophysiology
OAE is one of the 56 product codes in ArrHub’s electrophysiology vocabulary, each held with its FDA classification record as its citation. Vocabulary entry verified 20 September 2026.
Every record of this PMA number in ArrHub’s verified view, newest first. Routine notices are listed, never summarised away.
| Record | Type | Reason | Decision |
|---|---|---|---|
| P210027 FDA | original approval | empty | 2022-11-23 |
| P210027/S017 FDA | 30-Day Notice | Process Change - Manufacturer/Sterilizer/Packager/Supplier | 2026-08-17 |
| P210027/S016 FDA | Special (Immediate Track) | Labeling Change - Indications/instructions/shelf life/tradename | 2026-04-17 |
Source: FDA openFDA, device/pma, records of P210027, retrieved 2026-09-24 16:04 Eastern. 3 records in the verified view. Each identifier links to the FDA’s page.
What ArrHub adds to the record. Everything above this line is the agency’s; everything here is ArrHub’s, dated and attributed.
Record pair
No confirmed pair across the two registers for this record.
Resolved to
Johnson & Johnson
The register name above is resolved to its organisation under ArrHub’s alias table. Method: manual:m&a. Source: fda_applicant. Verified 20 September 2026.
First seen by ArrHub’s weekly snapshot: 2026-09-27 03:05 Eastern.
The stored record exactly as ArrHub holds it, for anyone who wants to check the page against it.
{
"id": "0e2f0e4d-67e5-484a-8557-9dae90237734",
"pma_key": "P210027",
"pma_number": "P210027",
"supplement_number": null,
"applicant": "Biosense Webster, Inc.",
"trade_name": "QDOT MICRO System",
"generic_name": "Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation",
"product_code": "OAE",
"advisory_committee_description": "Cardiovascular",
"decision_date": "2022-11-23",
"decision_code": "APPR",
"supplement_type": "",
"supplement_reason": "",
"date_received": "2021-07-06",
"source_url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P210027",
"verified_at": "2026-09-24T20:05:47.061+00:00",
"created_at": "2026-09-24T20:05:32.87905+00:00",
"collected_at": "2026-09-24T20:04:44.576+00:00",
"last_checked_at": "2026-09-24T20:05:47.061+00:00"
}The readable page is rendered from the record held in ArrHub’s verified view; the agency record at api.fda.gov governs where they differ.
Links open the agency’s own records. Unlabelled links open web pages. Links marked (JSON) open an agency’s data record, which a browser shows as plain text.
Report a broken link or a record that does not match its source: alerts@arrhub.com. Corrections are published, with their date, at arrhub.com/corrections.
© 2026 ArrHub. Content made available under licence.